Tonix Pharmaceuticals Holding Corp. Releases Preliminary Year-End 2024 Financial Results
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently published selected preliminary operating results and financial condition information for the year ending December 31, 2024. The company disclosed that it held approximately $98.8 million in cash and cash equivalents as of December 31, 2024, which is anticipated to sustain planned operations well into the first quarter of […]
More Stories
Court Blocks Subpoenas Tied to Criminal Probe of Fed Chair Jerome Powell
By Andrew Moran A federal judge blocked subpoenas issued to the Federal Reserve as part of a criminal investigation of...
Jeffrey Epstein Guard Called to Testify Before House Oversight Committee
By Jacki Thrapp One of the guards on duty when Jeffrey Epstein died in his cell will testify before the...
Senate Floor Fight Reveals How Far Apart Democrats and Republicans Are on DHS Shutdown
By Chase Smith For two days this week, senators took turns proposing ways to end the partial shutdown of the...
US Mortgage Rates Jump to 6.11 Percent
By Naveen Athrappully Mortgage rates have risen for the second consecutive week, moving up to 6.11 percent after briefly dipping...
US Sending More Marines, Warships to Middle East
By Ryan Morgan ARLINGTON, Va.—A U.S. Marine Expeditionary Unit is set to reposition to the Middle East amid ongoing military...
How the US Can Adjust to Middle East Oil Disruptions
By Kevin Stocklin The U.S.–Israeli war with Iran has brought heightened volatility to energy and equity markets, with the price...